Cargando…

The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review

BACKGROUND: A year following the onset of the COVID-19 pandemic, new infections and deaths continue to increase in Europe. Serological studies, through providing evidence of past infection, can aid understanding of the population dynamics of SARS-CoV-2 infection. OBJECTIVES: This systematic review o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaselli, Natasha Marcella, Hungerford, Daniel, Shenton, Ben, Khashkhusha, Arwa, Cunliffe, Nigel A., French, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562786/ https://www.ncbi.nlm.nih.gov/pubmed/34727115 http://dx.doi.org/10.1371/journal.pone.0250541

Ejemplares similares

Investigation of SARS-CoV-2 faecal shedding in the community: a prospective household cohort study (COVID-LIV) in the UK
por: Vaselli, Natasha Marcella, et al.
Publicado: (2021)

A Systematic Review of the Prevalence of Persistent Gastrointestinal Symptoms and Incidence of New Gastrointestinal Illness after Acute SARS-CoV-2 Infection
por: Hawkings, Michael J., et al.
Publicado: (2023)

Ecological assessment of the direct and indirect effects of routine rotavirus vaccination in Merseyside, UK using data from multiple health systems: a study protocol
por: Hungerford, Daniel, et al.
Publicado: (2014)

SARS-CoV-2 Seroprevalence Among First Responders in Northeastern Ohio, 2020
por: Zhang, Xiaochun, et al.
Publicado: (2022)

Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol
por: Setiabudi, Wega, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020–March 2021
por: Kleynhans, Jackie, et al.
Publicado: (2021)

Seroprevalence of SARS‐CoV‐2 in Utsunomiya City, Greater Tokyo, after the first pandemic in 2020
por: Nawa, Nobutoshi, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence and living conditions in Bamako (Mali): a cross-sectional multistage household survey after the first epidemic wave, 2020
por: Cissoko, Mady, et al.
Publicado: (2023)

SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves
por: de Visscher, Nathalie, et al.
Publicado: (2022)

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
por: Bajema, Kristina L., et al.
Publicado: (2020)

Reduction in hospitalisations for acute gastroenteritis-associated childhood seizures since introduction of rotavirus vaccination: a time-series and change-point analysis of hospital admissions in England
por: Hungerford, Daniel James, et al.
Publicado: (2019)

Coronavirus disease (COVID-19) – impact on vaccine preventable diseases
por: Hungerford, Daniel, et al.
Publicado: (2020)

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021
por: Mandolo, Jonathan, et al.
Publicado: (2021)

SARS-CoV-2: The Second Wave in Europe
por: Fokas, Athanassios S, et al.
Publicado: (2021)

SARS-CoV-2 Seroprevalence Post-First Wave among Primary Care Physicians in Catania (Italy)
por: Ledda, Caterina, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies in Thai adults during the first three epidemic waves
por: Lerdsamran, Hatairat, et al.
Publicado: (2022)

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya
por: Adetifa, Ifedayo M. O., et al.
Publicado: (2021)

First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate
por: Vial, Pablo A., et al.
Publicado: (2022)

Blood culture-negative infective endocarditis: are we looking hard enough?
por: Kirk, Frazer, et al.
Publicado: (2023)

The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021
por: Koirala, Archana, et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa
por: Kleynhans, Jackie, et al.
Publicado: (2022)

Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020–February 2022
por: Duong, Scotty, et al.
Publicado: (2023)

Rotavirus vaccine impact and socioeconomic deprivation: an interrupted time-series analysis of gastrointestinal disease outcomes across primary and secondary care in the UK
por: Hungerford, Daniel, et al.
Publicado: (2018)

Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
por: Shakiba, Maryam, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020
por: Flamand, Claude, et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence in French 9-year-old children and their parents after the first lockdown in 2020
por: Charles, Marie Aline, et al.
Publicado: (2023)

SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic
por: Pereckaitė, Laura, et al.
Publicado: (2021)

Seroprevalence and socioeconomic impact of the first SARS-CoV-2 infection wave in a small town in Navarre, Spain
por: Ribes, Marta, et al.
Publicado: (2023)

SARS-CoV-2 seroprevalence on the north coast of Peru: A cross-sectional study after the first wave
por: Moyano, Luz M., et al.
Publicado: (2023)

Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States
por: Davis, Jessica T., et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up
por: Recanatini, Claudia, et al.
Publicado: (2023)

High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo
por: Munyeku-Bazitama, Yannick, et al.
Publicado: (2023)

Seroprevalence of Lyme Borreliosis in Europe: Results from a Systematic Literature Review (2005–2020)
por: Burn, Leah, et al.
Publicado: (2023)

SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review
por: Grant, Rebecca, et al.
Publicado: (2021)

U.S. CDC support to international SARS-CoV-2 seroprevalence surveys, May 2020–February 2022
por: Ben Hamida, Amen, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June–July 2020
por: Díaz-Vélez, Cristian, et al.
Publicado: (2021)

Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
por: Solastie, Anna, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 antibodies in schoolchildren in the city of São Paulo, 2020
por: Kamioka, Gabriela Akemi, et al.
Publicado: (2023)

Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies
por: Hungerford, Daniel, et al.
Publicado: (2017)

SEROPREVALENCE OF ANTI-SARS-CoV-2 ANTIBODIES IN THE NORTHERN ITALY POPULATION BEFORE THE COVID-19 SECOND WAVE
por: Berselli, Nausicaa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5ofm93lgsoctmplp4ffsok3rq8